The Parathyroids (3rd Ed.) Basic and Clinical Concepts
Coordonnateurs : Bilezikian John P., Marcus Robert, Levine Michael A., Marcocci Claudio, Silverberg Shonni J, Potts John T.
The third edition of The Parathyroids, led by a new stellar editorial team, has been thoroughly updated to reflect the considerable advances in just about every aspect of PTH biology over the past decade. It continues to be the authoritative reference that spans the basic science of parathyroid hormone treatment to major clinical disorders in a superb, single compendium. This translational resource is invaluable to graduate students, fellows, researchers, and research clinicians in the fields of endocrinology, bone biology, osteology, and rheumatology.
- Contains chapters and information on noninvasive imaging, fracture healing, secondary diseases such as CKD, Vitamin D, cell signaling pathways, vascular calcification, as well as advances in genetics/genomics
- Includes essential updates on the critical importance of Vitamin D insufficiency and its relationship to secondary hyperparathyroidism
- Offers new insights into the underlying mechanisms of parathyroid hormone actions on osteocytes and sclerostin
- Examines essential updates in the understanding of secondary hyperparathyroidism associated with chronic kidney disease, facture healing, and vascular disease
Introduction/History Chapter
Section I: Molecular, Cellular, and Physiologic Aspects of the Parathyroids
Section II: Clinical Aspects of Primary Hyperparathyroidism
Section III: Non-Parathyroid Hypercalcemic States
Section VI: Secondary and Tertiary Hyperparathyroid States
Section V: The Hypoparathyroid States
Section VI: The Parathyroids and Osteoporosis
Dr. Marcus is Professor-Emeritus, Stanford University, where he served on the full-time medical faculty for almost 25 years, before joining the Emeritus faculty in 2001. At Stanford, he was located at the Veterans Affairs Medical Center, Palo Alto California, where he served as Director of the Aging Study Unit of the Geriatrics Research, Education, & Clinical Center from 1982-2001. Dr. Marcus enjoyed a long career as a clinical investigator in the fields of bone and mineral metabolism and osteoporosis medicine. His own research interests included diagnosis and therapy of primary hyperpara-thyroidism, interactions of the parathyroid-vitamin D axis with estrogen, age-related changes in the growth hormone-IGF axis, effects of growth hormone replacement for older men and women, metabolic and musculoskeletal effects of resistance exercise in older men and women, adolescent bone acquisition, and osteoporosis therapeutics. Dr. Marcus’ laboratory was a study site for many of the pivotal clinical trials in the osteoporosis field. These include the NIH Post-menopausal Estrogen/Progestin Interventions Trial (PEPI), Merck’s Fracture Intervention Trial (FIT), Lilly’s Multiple Outcomes of Raloxifene Intervention (MORE
Date de parution : 09-2014
Ouvrage de 946 p.
21.6x27.6 cm
Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).
Prix indicatif 215,20 €
Ajouter au panier